<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The role of <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> in the pathogenesis of <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> is controversial </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this case-controlled study was to determine whether <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> increases the risk of <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> or interferes with its clinical course </plain></SENT>
<SENT sid="2" pm="."><plain>A total of 808 white patients who developed <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> (cases) and 808 women with previous uneventful pregnancies (controls) matched for age and parity were evaluated for inherited and acquired <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> (factor V Leiden; factor II G20210A; <z:chebi fb="0" ids="25297">methylenetetrahydrofolate</z:chebi> reductase C677T; protein S, protein C, and <z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo>; anticardiolipin antibodies; <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>; and <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>Odds ratios (ORs) with 95% confidence intervals (CIs) for risk of being carriers of <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> in cases compared with controls and for risk of maternal life-threatening complications and adverse perinatal outcomes in preeclamptic patients with or without <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> were calculated </plain></SENT>
<SENT sid="4" pm="."><plain>Women with <z:e sem="disease" ids="C0341950,C0156669" disease_type="Disease or Syndrome" abbrv="">severe preeclampsia</z:e> (406 cases) had a higher risk (OR, 4.9; 95% CI, 3.5 to 6.9) of being carriers of either an inherited or acquired thrombophilic factor, except for protein S, protein C, and <z:e sem="disease" ids="C0272375" disease_type="Disease or Syndrome" abbrv="">antithrombin deficiency</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>In women with <z:e sem="disease" ids="C0269658" disease_type="Disease or Syndrome" abbrv="">mild preeclampsia</z:e> (402 cases), only prothrombin and homozygous <z:chebi fb="0" ids="25297">methylenetetrahydrofolate</z:chebi> reductase gene mutations were significantly more prevalent than in the controls </plain></SENT>
<SENT sid="6" pm="."><plain>Thrombophilic patients with <z:e sem="disease" ids="C0341950,C0156669" disease_type="Disease or Syndrome" abbrv="">severe preeclampsia</z:e> are at increased risk of <z:hpo ids='HP_0001919'>acute renal failure</z:hpo> (OR, 1.8; 95% CI, 1.5 to 2.2), <z:hpo ids='HP_0005521'>disseminated intravascular coagulation</z:hpo> (OR, 2.7; 95% CI, 1.1 to 6.4), <z:hpo ids='HP_0011419'>abruptio placentae</z:hpo> (OR, 2.6; 95% CI, 1.2 to 6.0) and perinatal mortality (OR, 1.7; 95% CI, 1.5 to 2.2) compared with nonthrombophilic preeclamptic patients </plain></SENT>
<SENT sid="7" pm="."><plain>Our study demonstrates a significant association between maternal <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> and <z:e sem="disease" ids="C0341950,C0156669" disease_type="Disease or Syndrome" abbrv="">severe preeclampsia</z:e> in white women </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0100724'>Thrombophilia</z:hpo> also augments the risk of life-threatening maternal complications and adverse perinatal outcomes in preeclamptic patients </plain></SENT>
</text></document>